Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1Unknown 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1Classical hematology 1

Conditions

Melanoma 1Anemia, Iron-Deficiency 1Anemia 1

Interventions

Peripheral Blood Stem Cell Transplantation 2siltuximab 1fludarabine phosphate 1ferric gluconate 1Transplantation 1Tacrolimus 1Pluvicto 1Methotrexate 1Iron-Dextran Complex 1Iron 1Holistic Health 1Filgrastim 1Erythrocyte Transfusion 1Epoetin Alfa 1Busulfan 1Blood Transfusion 1Blood Component Transfusion 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Anemia × Iron-Dextran Complex × Clear all
NCT06508827 2025-07-09

Intravenous Iron in Combination With Standard of Care Immunotherapy in Melanoma

Indiana University

Phase 2 Withdrawn
Classical hematologyDermatologic

Anemia, Melanoma, Anemia, Iron-Deficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡